The Bioinformatics Unit develops and establishes computer-aided methods for the identification and verification of new biomarkers for personalized diagnosis and prognosis of diseases as well as for the detection of novel therapeutic targets.
The Next-Generation Diagnostics Unit identifies and characterizes disease-associated nucleic acids for their application as diagnostic markers and therapeutic targets, and develops experimental methods for this purpose.
The work undertaken in this unit focuses on developing diagnostic and therapeutic applications of nanomaterials constructed by methods such as DNA self-assembly and molecular programming.
Fraunhofer Institute for Cell Therapy and Immunology IZI